These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 5071006)

  • 1. [Excitability of the spinal motor neurons in patients with Parkinsonism and athetosis treated with L-dopa].
    Messina C
    Riv Neurol; 1972; 42(3):225-31. PubMed ID: 5071006
    [No Abstract]   [Full Text] [Related]  

  • 2. [Study of H and T reflexes in Parkinsonism. Modification of these reflexes by L-Dopa].
    Krassoievitch M; Tissot R
    Encephale; 1971; 60(1):36-57. PubMed ID: 4253001
    [No Abstract]   [Full Text] [Related]  

  • 3. [Comparative analysis of the effects of Levodopa on sleep in patients with athetosis and parkinsonism treated and not treated with thalamolysis].
    Puca FM; Di Perri R
    Riv Neurol; 1970; 40(5):365-73. PubMed ID: 5503726
    [No Abstract]   [Full Text] [Related]  

  • 4. [2-year experiences with a combination treatment of Parkinsonism with L-dopa and a decarboxylase inhibitor (Benserazid, Ro 4-4602)].
    Birkmayer W; Linauer W; Mentasti M; Riederer P
    Wien Med Wochenschr; 1974 Jun; 124(22):340-4. PubMed ID: 4275492
    [No Abstract]   [Full Text] [Related]  

  • 5. [Treatment of Parkinsonic syndrome with levo-Dopa. Case reports].
    Rosati G; Agnetti V; Mura F; Granieri E
    Minerva Med; 1974 May; 65(33):1811-23. PubMed ID: 4602058
    [No Abstract]   [Full Text] [Related]  

  • 6. Is the decreasing responsiveness of axial motor symptoms to L-dopa in elderly parkinsonian patients related to age-associated nonparkinsonian pathologies?
    Ransmayr G; Künig G; Neubauer M; Wagner M; Bösch S; Kreczy-Kleedorfer B
    Adv Neurol; 1993; 60():685-9. PubMed ID: 8420211
    [No Abstract]   [Full Text] [Related]  

  • 7. A quantitative evaluation of the effects of L-dopa on Parkinson's disease.
    Velasco F; Velasco M
    Neuropharmacology; 1973 Feb; 12(2):89-99. PubMed ID: 4595553
    [No Abstract]   [Full Text] [Related]  

  • 8. [Long term treatment of a parkinsonism with l-dopa].
    Presthus J
    Tidsskr Nor Laegeforen; 1973 Oct; 93(28):2111-3. PubMed ID: 4590069
    [No Abstract]   [Full Text] [Related]  

  • 9. The role of a dihydromorphanthridine derivative in Parkinson's patients treated with L-dopa. A preliminary report.
    Wycis HT
    Confin Neurol; 1972; 34(2):130-5. PubMed ID: 4666056
    [No Abstract]   [Full Text] [Related]  

  • 10. Analysis of abnormal voluntary and involuntary movements with surface electromyography.
    Hallett M
    Adv Neurol; 1983; 39():907-14. PubMed ID: 6660128
    [No Abstract]   [Full Text] [Related]  

  • 11. [Treatment of parkinsonism with the drug L-DOPA].
    Stoliarova LG; Kistenev BA
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1973; 73(2):199-205. PubMed ID: 4795170
    [No Abstract]   [Full Text] [Related]  

  • 12. [L-dopa treatment of parkinsonism].
    Szulc-Kuberska J; Niewodniczy A; Poźniak-Patewicz E; Wolczyk-Orzechowska M
    Neurol Neurochir Pol; 1973; 7(1):63-8. PubMed ID: 4511385
    [No Abstract]   [Full Text] [Related]  

  • 13. [Quantitative rigor determination in Parkinson's disease. Myo-integration for therapy control of L-Dopa in combination with a decarboxylase inhibitor (Ro 8-0576)].
    Gehlen W; Eisenlohr JJ
    Nervenarzt; 1974 Jan; 45(2):22-9. PubMed ID: 4601993
    [No Abstract]   [Full Text] [Related]  

  • 14. Early detection of L-dopa response in parkinsonian patients with a standardized tracking test.
    Albani C; Buck A
    Adv Neurol; 1993; 60():386-9. PubMed ID: 8420158
    [No Abstract]   [Full Text] [Related]  

  • 15. H-reflex in patients with parkinsonism: effect of levodopa.
    Herbison GJ
    Arch Phys Med Rehabil; 1973 Jul; 54(7):291-5 passim. PubMed ID: 4718235
    [No Abstract]   [Full Text] [Related]  

  • 16. [Results of treatment of Parkinsonism with L-dopa].
    De Divitiis E; D'Andrea F; Signorelli CD
    Sist Nerv; 1970; 22(2):99-108. PubMed ID: 5504563
    [No Abstract]   [Full Text] [Related]  

  • 17. [Experiences in the treatment of Parkinsonism with L-dopa. IV. Effects on the experimental extrapyranidal brady-akinesia in cats].
    Bergamini L; Bonzanino O; Brignolio F; Fabiani A; Fariello R; Mombelli AM; Mutani R; Pisani W; Postir A; Quattroccolo G; Riccio A; Sabbatini F; Sandigliano G; Schiffer D
    Riv Patol Nerv Ment; 1970 Feb; 91(1):62-6. PubMed ID: 5524934
    [No Abstract]   [Full Text] [Related]  

  • 18. [Psychologic evaluation of amantadine treatment of parkinsonism and comparative analysis of the effects with L-dopa].
    Puca FM; Micalizzi V; Megna GF; Barbieri NF; Pigneri MT
    Acta Neurol (Napoli); 1971; 26(6):707-30. PubMed ID: 4946491
    [No Abstract]   [Full Text] [Related]  

  • 19. [The therapeutic effect of L-dopa].
    Groneberg P; Struppler A
    Naturwissenschaften; 1972 Nov; 59(11):492-6. PubMed ID: 4657650
    [No Abstract]   [Full Text] [Related]  

  • 20. [L-dopa treatment of persons with parkinsonism in a hospital for geriatric rehabilitation].
    Antonini F; Baroni A; Roveyaz L
    Sist Nerv; 1970; 22(2):74-81. PubMed ID: 5504560
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.